Survival RateCell SurvivalDisease-Free SurvivalSurvival AnalysisTreatment OutcomeSurvivalGraft SurvivalRetrospective StudiesPrognosisKaplan-Meier EstimateTime FactorsFollow-Up StudiesNeoplasm StagingCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsProportional Hazards ModelsNeoplasm Recurrence, LocalOphthalmic SolutionsLung NeoplasmsLiver NeoplasmsMultivariate AnalysisAdenocarcinomaProspective StudiesLymphatic MetastasisRisk FactorsActuarial AnalysisChemotherapy, AdjuvantApoptosisAntineoplastic AgentsTumor Markers, BiologicalLiver TransplantationCisplatinCarcinoma, HepatocellularCarcinoma, Squamous CellBreast NeoplasmsAge FactorsNeoplasm MetastasisImmunohistochemistryCohort StudiesPostoperative ComplicationsRecurrenceRegistriesHepatectomyDisease ProgressionRadiotherapy, AdjuvantStomach NeoplasmsCarcinoma, Non-Small-Cell LungCyclophosphamideDoxorubicinVincristineReoperationFluorouracilCell Line, TumorRisk AssessmentNeoplasm InvasivenessKidney TransplantationBrain NeoplasmsPancreatic NeoplasmsRadiotherapy DosageDrug Administration ScheduleLife TablesGraft RejectionEsophageal NeoplasmsRemission InductionCarcinomaColorectal NeoplasmsSignal TransductionLymph Node ExcisionMice, Inbred C57BLPredictive Value of TestsDisease Models, AnimalTransplantation, HomologousIncidenceNeoplasmsGastrectomyNeoadjuvant TherapyCell ProliferationPrednisoneEtoposideBile Duct NeoplasmsChemoembolization, TherapeuticTissue DonorsBone NeoplasmsCardiopulmonary ResuscitationJapanImmunosuppressive AgentsCells, CulturedSEER ProgramRectal NeoplasmsDose-Response Relationship, DrugHeart ArrestChi-Square DistributionSalvage TherapySarcomaGene Expression Regulation, NeoplasticRadiotherapyCholangiocarcinomaMice, Inbred BALB CAnalysis of VarianceDose Fractionation